InstaMed® Pharmaceuticals, a biotechnology innovator, is pioneering the first patented non-injectable peptide delivery system ...
By Sriparna Roy Dec 8 (Reuters) - Recursion Pharma, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths in the ...
Opinion
Business and Financial Times on MSNOpinion
Farmers’Day25: How we can partner Europe to advance the salt industry through value addition
By Kwame A. ApeaningGhana’s salt industry holds enormous potential, not only as a raw material supplier but also as a driver of industrialisation and export growth. With vast natural deposits ...
ESTERO, FL / ACCESS Newswire / December 4, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) (“Aspire” or the “Company”), ...
Learn more about whether Nurix Therapeutics, Inc. or Recursion Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
US Treasury is preparing guidance to ease the 15% minimum tax, allowing major companies to claim full R&D deductions worth up ...
Tiffany Shimada has joined Dorsey & Whitney LLP as a Partner in the Trademark group in Salt Lake City, the international law ...
The US Treasury Department is preparing to issue new tax guidance that could help companies save billions more. The move, ...
Ecstasy or molly is often linked to festival and rave culture. But the so-called party drug carries far more risks today than it did decades ago.
The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for TRN-257, a controlled-release, low-sodium oxybate product, for the treatment of cataplexy or excessive ...
These drugs can be detected in surface water,” said lead researcher Gustavo Salcedo of the University of Massachusetts, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results